BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28589369)

  • 1. Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk.
    Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
    Breast Cancer Res Treat; 2017 Aug; 165(1):215-223. PubMed ID: 28589369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk prediction: an update to the Rosner-Colditz breast cancer incidence model.
    Rice MS; Tworoger SS; Hankinson SE; Tamimi RM; Eliassen AH; Willett WC; Colditz G; Rosner B
    Breast Cancer Res Treat; 2017 Nov; 166(1):227-240. PubMed ID: 28702896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for breast cancer according to estrogen and progesterone receptor status.
    Colditz GA; Rosner BA; Chen WY; Holmes MD; Hankinson SE
    J Natl Cancer Inst; 2004 Feb; 96(3):218-28. PubMed ID: 14759989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a breast cancer risk prediction model developed for Black women.
    Boggs DA; Rosenberg L; Pencina MJ; Adams-Campbell LL; Palmer JR
    J Natl Cancer Inst; 2013 Mar; 105(5):361-7. PubMed ID: 23411594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.
    Rosner BA; Colditz GA; Hankinson SE; Sullivan-Halley J; Lacey JV; Bernstein L
    Breast Cancer Res Treat; 2013 Nov; 142(1):187-202. PubMed ID: 24158759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study.
    Glynn RJ; Colditz GA; Tamimi RM; Chen WY; Hankinson SE; Willett WW; Rosner B
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1187-1194. PubMed ID: 31015199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk prediction with a log-incidence model: evaluation of accuracy.
    Rockhill B; Byrne C; Rosner B; Louie MM; Colditz G
    J Clin Epidemiol; 2003 Sep; 56(9):856-61. PubMed ID: 14505770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
    Chen WY; Colditz GA
    Nat Clin Pract Oncol; 2007 Jul; 4(7):415-23. PubMed ID: 17597706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurses' health study: log-incidence mathematical model of breast cancer incidence.
    Rosner B; Colditz GA
    J Natl Cancer Inst; 1996 Mar; 88(6):359-64. PubMed ID: 8609645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis.
    Linos E; Spanos D; Rosner BA; Linos K; Hesketh T; Qu JD; Gao YT; Zheng W; Colditz GA
    J Natl Cancer Inst; 2008 Oct; 100(19):1352-60. PubMed ID: 18812552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study.
    Rosner B; Colditz GA; Iglehart JD; Hankinson SE
    Breast Cancer Res; 2008; 10(4):R55. PubMed ID: 18598349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
    Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
    J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the Rosner-Colditz risk prediction model to estimate sexual orientation group disparities in breast cancer risk in a U.S. cohort of premenopausal women.
    Austin SB; Pazaris MJ; Rosner B; Bowen D; Rich-Edwards J; Spiegelman D
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2201-8. PubMed ID: 23035180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
    Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
    Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.
    Habibi G; Leung S; Law JH; Gelmon K; Masoudi H; Turbin D; Pollak M; Nielsen TO; Huntsman D; Dunn SE
    Breast Cancer Res; 2008; 10(5):R86. PubMed ID: 18925950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.